High expression of FOSB+, NEAT1+, or XIST+ tumor cell-associated genes such as FSTL3, VTN, PAPPA, CCN1, RRAD, and GPRIN3 may predict poor survival in patients with LUSC, suggesting that these genes act as prognosis biomarkers. Here, FOSB is linked to neoplasm.